Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Ghorashian, Sara; Malard, Florent; Yüksel, Meltem Kurt; Mauff, Katya; Hoogenboom, Jorinde D.; Urbano-Ispizua, Alvaro; Kuball, Jürgen; de la Camara, Rafael; Ljungman, Per; Ruggeri, Annalisa; Chabannon, Christian

doi:https://doi.org/10.1038/s41409-021-01483-8

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

DSpace/Manakin Repository

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Ghorashian, Sara; Malard, Florent; Yüksel, Meltem Kurt; Mauff, Katya; Hoogenboom, Jorinde D.; Urbano-Ispizua, Alvaro; Kuball, Jürgen; de la Camara, Rafael; Ljungman, Per; Ruggeri, Annalisa; Chabannon, Christian

(2022) Bone Marrow Transplantation, volume 57, issue 2, pp. 299 - 301

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: COVID-19, Europe, Humans, Immunotherapy, Adoptive, Retrospective Studies, SARS-CoV-2, Transplantation, Hematology, Letter

DOI: https://doi.org/10.1038/s41409-021-01483-8

ISSN: 0268-3369

Publisher: Nature Publishing Group

(Peer reviewed)